OSUR News and Press, OraSure Technologies Inc. From 02/14/23

OraSure Technologies press release ( NASDAQ: OSUR ): Q4 Non-GAAP EPS of $0.36 beats by $0.32 . Revenue of $123.08M (+93.6% Y/Y) beats by $26.2M . For further details see: OraSure Technologies Non-GAAP EPS of $0.36 beats by $0.32, revenue of $123.08M beats by $26.2M

InteliSwab ® revenue of $88.9 million in Q4, up 12% sequentially; wins two new federal government contracts extending the tail on InteliSwab ® revenue Signs a deal with Quest Diagnostics Genomic Sequencing Services for saliva collection kits Q4 ...

OraSure Technologies ( NASDAQ: OSUR ) is scheduled to announce Q4 earnings results on Tuesday, February 14th, after market close. The consensus EPS Estimate is $0.04 (vs. -$0.14 in 4Q22) and the consensus Revenue Estimate is $96.88M (+52.4% Y/Y). Over the last 1 year, OSUR h...

BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, February 14, 2023. February...

BETHLEHEM, Pa., Dec. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, will ring the closing bell for the Nasdaq Stock Market this afternoon in honor of World AIDS Day. World AIDS Day is commemorated annually on December 1 to raise a...

BETHLEHEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Ken McGrath, Chief Financial Officer, will participa...

OraSure Technologies, Inc. (OSUR) Q3 2022 Earnings Conference Call November 08, 2022 05:00 PM ET Company Participants Scott Gleason - Senior Vice President of Communications and Investor Relations Carrie Manner - President and Chief Executive Officer Kenneth McGr...

OraSure Technologies press release ( NASDAQ: OSUR ): Q3 Non-GAAP EPS of $0.13 beats by $0.10 . Revenue of $116.46M (+116.1% Y/Y) beats by $24.75M . The Company is guiding toward 4Q22 revenue of $95 to $100 million vs $88.06M consensus, representing 49% to ...

OraSure Technologies ( NASDAQ: OSUR ) is scheduled to announce Q3 earnings results on Tuesday, November 8th, after market close. The consensus EPS Estimate is $0.03 (+114.3% Y/Y) and the consensus Revenue Estimate is $91.71M (+70.1% Y/Y). Over the last 1 year, OSUR h...

FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of...